Showing results (41-50 of 8,763) with videos related to
Sort By:
Pageof 877
Pediatric Blood & Cancer|April 15, 2017
Childhood osteosarcoma: Incidence and survival in Argentina. Report from the National Pediatric Cancer Registry, ROHA Network 2000-2013F Moreno, W Cacciavillano, M Cipolla, et al.Pediatric Blood & Cancer|March 23, 2019
Measurable residual disease monitoring using Wilms tumor gene 1 expression in childhood acute myeloid leukemia based on child-specific reference valuesKristian Løvvik Juul-Dam, Charlotte Guldborg Nyvold, Helen Vålerhaugen, et al.Pediatric Blood & Cancer|March 23, 2019
Holistic support coupled with prospective tracking reduces abandonment in childhood cancers: A report from IndiaShalini Jatia, Maya Prasad, Amey Paradkar, et al.Pediatric Blood & Cancer|April 25, 2017
Medication prior authorization in pediatric hematology and oncologyDavid S Dickens, Brad H PollockPediatric Blood & Cancer|April 25, 2017
Infection-related mortality in Hispanic and non-Hispanic children with cancerRochelle R Smits-Seemann, Jacob Pettit, Hongyan Li, et al.Pediatric Blood & Cancer|April 25, 2017
Results for patients with sarcoma not otherwise specified and other diagnoses than Ewing sarcoma treated according to the Euro-EWING 99 trialJudith Amalie Frank, Andreas Ranft, Michael Paulussen, et al.Pediatric Blood & Cancer|March 22, 2021
Multimodality treatment including whole pleura radiation therapy for DICER1-associated pediatric pleuropulmonary blastomaCaressa Hui, Danielle H Shin, Adrienne Wakeling, et al.Pediatric Blood & Cancer|March 24, 2021
Validated quantitative needs assessment differences in the management of children with central nervous system cancer between Brazil, an upper middle-income country, and the United States of America, a high income countryAllison N Fischer, Roberto Roecker, Nasjla Saba da Silva, et al.Pediatric Blood & Cancer|July 28, 2011
Treatment of children with poor risk solid tumors by further escalation of the VETOPEC regimen including very high-dose cyclophosphamide and peripheral stem cell support: an Australian and New Zealand Children's Hematology and Oncology Group studyGeoffrey B McCowage, Robert Mrongovius, Frank Alvaro, et al.Pediatric Blood & Cancer|July 15, 2011
Xmn1-G γ polymorphism and clinical predictors of severity of disease in β-thalassemia intermediaSapna Oberoi, Reena Das, Inusha Panigrahi, et al.Pageof 877